(Total Views: 461)
Posted On: 05/20/2021 8:28:20 AM
Post# of 145247
The nearest likely catalyst is longhaulers results. From the results we have from the 4 patients that have went public they should be very good. With the large activist longhaulers population word will spread like wildfire and the larger phase 3 should fill very fast. Very good chance we can get results on phase 3 before the end of the year.
Before then we may get some ancedotal results out of the Philippines and India and even sales out of the Philippines but I don't think those are going to move any mountains.
Next big catalyst of course Brazil interim results.
Possible BTD for cancer but I wouldn't trust the FDA on that one no matter how good the results.
I wouldn't doubt that the FDA screws us on the combo BLA again. Nader just needs to get the mono protocol approved and start that trial now.
Before then we may get some ancedotal results out of the Philippines and India and even sales out of the Philippines but I don't think those are going to move any mountains.
Next big catalyst of course Brazil interim results.
Possible BTD for cancer but I wouldn't trust the FDA on that one no matter how good the results.
I wouldn't doubt that the FDA screws us on the combo BLA again. Nader just needs to get the mono protocol approved and start that trial now.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)